S&P Futures
5,894.00 -12.00 (-0.20%) Dow Futures
43,467.00 -51.00 (-0.12%) Nasdaq Futures
20,402.50 -81.00 (-0.40%) Russell 2000 Futures
2,291.20 0.00 (0.00%) Crude Oil
70.20 +0.98 (+1.42%) Gold
2,749.50 +19.50 (+0.71%)
Nxera Pharma Co., Ltd. (4565.T)
- GlobeNewswire
Nxera Pharma to Host R&D Day 2024
Nxera Pharma Co., Ltd. will hold an R&D Day on 6 November 2024 at 16:30 JST. The meeting will be held virtually via Zoom webinar. Please click here to pre-register for the event. Date: Wednesday, 6 November 2024 Time: 16:30 – 18:00 JST (7:30 – 9:00 GMT) Presenters: Chris Cargill, President and CEO Dr. Matt Barnes, Executive Officer, President of Nxera Pharma UK and Head of R&DDr. Makoto Sugita, Executive Officer, Chief Medical Officer (CMO) and President of Nxera Pharma JapanHironoshin Nomura, E
- GlobeNewswire
Nxera Pharma Appoints Experienced Commercial R&D Executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma Japan
Dr. Sugita – formerly Vice President, Head of R&D for Bristol Myers Squibb in Japan – brings nearly 20 years’ experience in R&D and commercial roles working within the Japanese businesses of global pharmaceutical companies Tokyo, Japan and Cambridge, UK, 1 October 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Dr. Makoto Sugita, M.D., Ph.D., MBA, as President of Nxera Pharma Japan, and Exec
